631 related articles for article (PubMed ID: 2474526)
1. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.
Ema H; Suda T; Sakamoto S; Tomonaga T; Tsunoda J; Muroi K; Komatsu N; Miwa A; Ohsaka A; Yoshida M
Jpn J Cancer Res; 1989 Jun; 80(6):577-82. PubMed ID: 2474526
[TBL] [Abstract][Full Text] [Related]
2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation.
Neidhart J; Mangalik A; Kohler W; Stidley C; Saiki J; Duncan P; Souza L; Downing M
J Clin Oncol; 1989 Nov; 7(11):1685-92. PubMed ID: 2478670
[TBL] [Abstract][Full Text] [Related]
4. Short-term rhG-CSF priming before chemotherapy does mobilize blood progenitors but does not prevent chemotherapy induced myelotoxicity: a randomized study of patients with non-Hodgkin's lymphomas.
Hansen PB; Johnsen HE; Ralfkiaer E; Jensen L; Gaarsdal E; Hansen NE
Leuk Lymphoma; 1995 Nov; 19(5-6):453-60. PubMed ID: 8590846
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
[TBL] [Abstract][Full Text] [Related]
6. Decreased levels of myeloid progenitor cells associated with long-term administration of recombinant human granulocyte colony-stimulating factor in patients with autoimmune neutropenia.
Taniguchi S; Shibuya T; Harada M; Niho Y
Br J Haematol; 1993 Mar; 83(3):384-7. PubMed ID: 7683484
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-colony-stimulating factor enhances the circulating hematopoietic progenitors in lung cancer patients treated with cisplatin-containing regimens.
Mukai J; Shimizu E; Ogura T
Jpn J Cancer Res; 1992 Jul; 83(7):746-53. PubMed ID: 1381342
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
9. Correction of canine cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor.
Lothrop CD; Warren DJ; Souza LM; Jones JB; Moore MA
Blood; 1988 Oct; 72(4):1324-8. PubMed ID: 2458781
[TBL] [Abstract][Full Text] [Related]
10. Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF).
Tamai H; Mukuta T; Matsubayashi S; Fukata S; Komaki G; Kuma K; Kumagai LF; Nagataki S
J Clin Endocrinol Metab; 1993 Nov; 77(5):1356-60. PubMed ID: 7521347
[TBL] [Abstract][Full Text] [Related]
11. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
Fukutani H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Tabata M; Hirano A; Mizunuma N
Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.
Taylor KM; Jagannath S; Spitzer G; Spinolo JA; Tucker SL; Fogel B; Cabanillas FF; Hagemeister FB; Souza LM
J Clin Oncol; 1989 Dec; 7(12):1791-9. PubMed ID: 2479719
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients.
Bronchud MH; Potter MR; Morgenstern G; Blasco MJ; Scarffe JH; Thatcher N; Crowther D; Souza LM; Alton NK; Testa NG
Br J Cancer; 1988 Jul; 58(1):64-9. PubMed ID: 2458748
[TBL] [Abstract][Full Text] [Related]
14. Detecting of the minimal residual disease contaminated in peripheral blood stem cell transplantation in the B-cell malignant lymphoma patients.
Nagasu M; Aizawa S; Hojo H; Tsuda A; Yaguchi M; Nakano M; Toyama K
Am J Hematol; 1992 Oct; 41(2):107-12. PubMed ID: 1384313
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
Tanikawa S; Nakao I; Tsuneoka K; Nara N
Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
[TBL] [Abstract][Full Text] [Related]
16. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium.
Gabrilove JL; Jakubowski A; Scher H; Sternberg C; Wong G; Grous J; Yagoda A; Fain K; Moore MA; Clarkson B; Oettgen HF; Alton K; Welte K; Souza L
N Engl J Med; 1988 Jun; 318(22):1414-22. PubMed ID: 2452983
[TBL] [Abstract][Full Text] [Related]
17. Propylthiouracil (PTU)-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF).
Balkin MS; Buchholtz M; Ortiz J; Green AJ
Thyroid; 1993; 3(4):305-9. PubMed ID: 7509672
[TBL] [Abstract][Full Text] [Related]
18. In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells.
Andrews RG; Briddell RA; Knitter GH; Opie T; Bronsden M; Myerson D; Appelbaum FR; McNiece IK
Blood; 1994 Aug; 84(3):800-10. PubMed ID: 7519077
[TBL] [Abstract][Full Text] [Related]
19. [Clinical application of recombinant human colony-stimulating factor (rhG-CSF) in bone marrow transplantation].
Takahashi S; Kodo H
Rinsho Ketsueki; 1990 May; 31(5):589-96. PubMed ID: 1697628
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease.
Devereaux S; Linch DC; Gribben JG; McMillan A; Patterson K; Goldstone AH
Bone Marrow Transplant; 1989 Jan; 4(1):49-54. PubMed ID: 2647187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
